🔥 EXCELENT NEWS: Recent study published Feb 1, 2024, demonstrates N-acetyl cysteine (NAC), a well-known OTC supplement, is effective against all SARS-COV-2 variants studied in both human lung cells & humanized mouse model -"Treatment with NAC inhibits SARS-CoV-2 infection in vivo" -Overcomes "current therapeutic interventions for COVID-19 only target viral proteins, which promotes the emergence of variants that evade vaccine-induced immunity or resistance to antiviral drugs" -"reduction in ROS levels induced by prolonged IKE administration and GSH or NAC treatment impaired the SARS-CoV-2 viral cycle" -"The mechanistic explanation has been given that the antioxidant, anti-inflammatory, and anti-thrombotic effects of NAC counteract viral pneumonia" "our results demonstrate the direct antiviral effects of NAC on lung epithelial cells in addition to its immunomodulatory effects. We therefore support the use of NAC and other antioxidant drugs as safe and accessible anti-SARS-CoV-2 therapies against current and future variants" Source: https://academic.oup.com/jmcb/article/16/3/mjae004/7596546
See Tweet